Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
ACS Nano|January 12, 2024
Nanoparticle-Conjugated Toll-Like Receptor 9 Agonists Improve the Potency, Durability, and Breadth of COVID-19 VaccinesBen S Ou, Julie Baillet, Vittoria C T M Picece, et al.Biomacromolecules|July 2, 2021
Engineering Insulin Cold Chain Resilience to Improve Global AccessCaitlin L Maikawa, Joseph L Mann, Aadithya Kannan, et al.Journal of Biomedical Materials Research. Part A|May 6, 2021
Modulation of injectable hydrogel properties for slow co-delivery of influenza subunit vaccine components enhance the potency of humoral immunityOlivia M Saouaf, Gillie A Roth, Ben S Ou, et al.Science Advances|April 11, 2025
Generation of an inflammatory niche in a hydrogel depot through recruitment of key immune cells improves efficacy of mRNA vaccinesEmily L Meany, John H Klich, Carolyn K Jons, et al.Biorxiv : the Preprint Server for Biology|July 19, 2024
Generation of an inflammatory niche in an injectable hydrogel depot through recruitment of key immune cells improves efficacy of mRNA vaccinesEmily L Meany, John H Klich, Carolyn K Jons, et al.Advanced Materials (Deerfield Beach, Fla.)|October 15, 2021
Hydrogel-Based Slow Release of a Receptor-Binding Domain Subunit Vaccine Elicits Neutralizing Antibody Responses Against SARS-CoV-2Emily C Gale, Abigail E Powell, Gillie A Roth, et al.Biorxiv : the Preprint Server for Biology|April 6, 2021
Hydrogel-based slow release of a receptor-binding domain subunit vaccine elicits neutralizing antibody responses against SARS-CoV-2Emily C Gale, Abigail E Powell, Gillie A Roth, et al.Biorxiv : the Preprint Server for Biology|August 14, 2023
Saponin Nanoparticle Adjuvants Incorporating Toll-Like Receptor Agonists Drive Distinct Immune Signatures and Potent Vaccine ResponsesBen S Ou, Julie Baillet, Maria V Filsinger Interrante, et al.Science Advances|August 7, 2024
Saponin nanoparticle adjuvants incorporating Toll-like receptor agonists drive distinct immune signatures and potent vaccine responsesBen S Ou, Julie Baillet, Maria V Filsinger Interrante, et al.Science Advances|April 8, 2022
Delivery of CAR-T cells in a transient injectable stimulatory hydrogel niche improves treatment of solid tumorsAbigail K Grosskopf, Louai Labanieh, Dorota D Klysz, et al.Pageof 2